Amidopyrazole inhibitors of interleukin receptor-associated kinases

A compound of the following formula:

• wherein R1 is aryl, heteroaryl, heterocyclyl or (C1-6 alkyl)R6, wherein said aryl, heteroaryl, and heterocyclyl groups are optionally substituted with one or two substituents selected from the group consisting of halo, cyano, R4, C3-8 cycloalkyl, C1-3 aminoalkyl, C1-3 hydroxyalkyl, OR4, NR4R5, NR4COR6, NR4SO2R6, SO2NR4R5, CONR4R5 and CONR4R5;
• R2 is aryl, heteroaryl, C3-8 cycloalkyl, heterocyclyl or (C1-6 alkyl)R6, wherein said aryl, heteroaryl, cycloalkyl and heterocyclyl groups are optionally substituted with one or two substituents selected from the group consisting of halo, cyano, oxo, hydroxyl, imino, hydroxyimino, R4, OR4, O(C3-8 cycloalkyl), (C═O)OR4, SOmR6, SOmR4, NR4R5, SO2NR4R5 and NR4SO2R6;
• R3 is halo, cyano, oxo, hydroxyl, imino, hydroxyimino, R4, OR4, C3-8 cycloalkyl, SOmR6, SOmR4NR4R5 or (C═O)NR4R5, NR4(CO)R6, SOmNR4R5 and NR4SO2R6;
• R4 is hydrogen or C1-6 alkyl, wherein said alkyl is optionally substituted with one to three halo or hydroxyl;
• R5 is hydrogen or C1-6 alkyl, wherein said alkyl is optionally substituted with halo or hydroxyl;
• R6 is aryl, heteroaryl, C3-8 cycloalkyl or heterocyclyl;
• m is an integer from zero to two;
• or a pharmaceutically acceptable salt thereof.